These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12042562)

  • 1. Primary intestinal and thoracic lymphangiectasia: a response to antiplasmin therapy.
    MacLean JE; Cohen E; Weinstein M
    Pediatrics; 2002 Jun; 109(6):1177-80. PubMed ID: 12042562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide in the treatment of intestinal lymphangiectasia.
    Ballinger AB; Farthing MJ
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):699-702. PubMed ID: 9744700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal lymphangiectasia: a rare cause of gastrointestinal bleeding?
    Stovicek J; Keil R; Pálová S; Lochmannová J
    Scand J Gastroenterol; 2007 Mar; 42(3):418. PubMed ID: 17354127
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe Refractory Anemia in Primary Intestinal Lymphangiectasia. A Case Report.
    Balaban VD; Popp A; Grasu M; Vasilescu F; Jinga M
    J Gastrointestin Liver Dis; 2015 Sep; 24(3):369-73. PubMed ID: 26405709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful resection of localized intestinal lymphangiectasia post-Fontan: role of (99m)technetium-dextran scintigraphy.
    Connor FL; Angelides S; Gibson M; Larden DW; Roman MR; Jones O; Currie BG; Day AS; Bohane TD
    Pediatrics; 2003 Sep; 112(3 Pt 1):e242-7. PubMed ID: 12949320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal lymphangiectasia and antiplasmin therapy.
    Cohen SA; Diuguid DL; Whitlock RT; Holt PR
    Gastroenterology; 1992 Jun; 102(6):2193. PubMed ID: 1587455
    [No Abstract]   [Full Text] [Related]  

  • 7. Intestinal lymphangiectasia markedly improved with antiplasmin therapy.
    Mine K; Matsubayashi S; Nakai Y; Nakagawa T
    Gastroenterology; 1989 Jun; 96(6):1596-9. PubMed ID: 2714582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy?
    Heresbach D; Raoul JL; Bretagne JF; Gosselin M
    Gastroenterology; 1991 Apr; 100(4):1152-3. PubMed ID: 2001819
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal lymphangiectasia: lack of efficacy of antiplasmin therapy?
    Mine K
    Gastroenterology; 1991 Dec; 101(6):1761. PubMed ID: 1955150
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Profile, Response to Therapy, and Outcome of Children with Primary Intestinal Lymphangiectasia.
    Prasad D; Srivastava A; Tambe A; Yachha SK; Sarma MS; Poddar U
    Dig Dis; 2019; 37(6):458-466. PubMed ID: 31030202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide in intestinal lymphangiectasia: lack of a clinical response and failure to alter lymphatic function in a guinea pig model.
    Makhija S; von der Weid PY; Meddings J; Urbanski SJ; Beck PL
    Can J Gastroenterol; 2004 Nov; 18(11):681-5. PubMed ID: 15565209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of protein-losing enteropathy induced by intestinal lymphangiectasia in a liver cirrhosis patient with octreotide: a case report.
    Lee HL; Han DS; Kim JB; Jeon YC; Sohn JH; Hahm JS
    J Korean Med Sci; 2004 Jun; 19(3):466-9. PubMed ID: 15201518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary intestinal lymphangiectasia (Waldmann's disease).
    Vignes S; Bellanger J
    Orphanet J Rare Dis; 2008 Feb; 3():5. PubMed ID: 18294365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SYSTEMIC LYMPHATIC ABNORMALITIES ASSOCIATED WITH GASTROINTESTINAL PROTEIN LOSS SECONDARY TO INTESTINAL LYMPHANGIECTASIA.
    POMERANTZ M; WALDMANN TA
    Gastroenterology; 1963 Dec; 45():703-11. PubMed ID: 14134004
    [No Abstract]   [Full Text] [Related]  

  • 15. A case with intestinal lymphangiectasia successfully treated with slow-release octreotide.
    Filik L; Oguz P; Koksal A; Koklu S; Sahin B
    Dig Liver Dis; 2004 Oct; 36(10):687-90. PubMed ID: 15506669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to treat an extensive form of primary intestinal lymphangiectasia?
    Troskot R; Jurčić D; Bilić A; Gomerčić Palčić M; Težak S; Brajković I
    World J Gastroenterol; 2015 Jun; 21(23):7320-5. PubMed ID: 26109821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature.
    Kwon Y; Kim ES; Choe YH; Kim MJ
    BMC Pediatr; 2021 Jan; 21(1):21. PubMed ID: 33407260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary intestinal lymphangiectasia successfully treated with octreotide.
    Kuroiwa G; Takayama T; Sato Y; Takahashi Y; Fujita T; Nobuoka A; Kukitsu T; Kato J; Sakamaki S; Niitsu Y
    J Gastroenterol; 2001 Feb; 36(2):129-32. PubMed ID: 11227670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment?
    Sari S; Baris Z; Dalgic B
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):454-7. PubMed ID: 20512058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waldmann's disease: a rare cause of protein losing enteropathy in an adult patient.
    Martins CR; Gagnaire A; Rostain F; Lepage C
    Rev Esp Enferm Dig; 2017 May; 109(5):385-388. PubMed ID: 28376626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.